PCR181 Health-Related Quality-of-Life of Patients Treated with Repotrectinib for Neurotrophic Tyrosine Receptor Kinase (NTRK)-Positive Advanced Solid Tumors: Results from TRIDENT-1. - Sherif, B.; Besse, B.; Solomon, B.; Bazhenova, L.; Kim, D.W.; Lin, J.J.; Wolf, J.; Popat, S.; Goto, K.; de Langen, A.J.; Springfeld, C.; Reynolds, M.; et al. (Value in Health, 2023)